U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Specific DNA probes in diagnostic microbiology

Patent 4358535 Issued on November 9, 1982. Estimated Expiration Date: Icon_subject December 8, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3755086

Method for the genetic detection of microorganisms
Patent #: 3930956
Issued on: 01/06/1976
Inventor: Juni

Test kit for the genetic detection of microorganisms
Patent #: 4038143
Issued on: 07/26/1977
Inventor: Juni

Macromolecular environment control in specific receptor assays Patent #: 4275149
Issued on: 06/23/1981
Inventor: Litman ,   et al.

Inventors

Assignee

Application

No. 06/213803 filed on 12/08/1980

US Classes:

435/5, Involving virus or bacteriophage435/34, Determining presence or kind of micro-organism; use of selective media435/35, Using radioactive material435/36, Streptococcus; staphylococcus435/37, Nitrate to nitrite reducing bacteria435/38, Enterobacteria435/6, Involving nucleic acid436/504, Radioactive label436/63, BIOLOGICAL CELLULAR MATERIAL TESTED436/811, TEST FOR NAMED DISEASE, BODY CONDITION OR ORGAN FUNCTION536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)536/23.7Encodes a microbial polypeptide

Examiners

Primary: Warden, Robert J.

Attorney, Agent or Firm

International Classes

C12Q 1/68 (20060101)
C12Q 1/68 (20060101)

Abstract

Method and compositions for infectious disease diagnosis and epidemiology involving labeled nucleotide probes complementary to nucleic acid coding for a characteristic pathogen product. Clinical isolates are cultivated, expanding the number of microorganisms, the resulting colonies lysed, the genome normally denatured and then fixed. Alternatively, clinical samples (stool, sputum, pus, etc.) are spotted onto an inert support. The sample is treated in such a way that the DNA is liberated from microbes present in the sample and complexed onto the support. The DNA is normally denatured and fixed in this process. Subsequently, a labelled polynucleotide probe specific for a DNA sequence characteristic of a pathogenic product suspected of being present in the clinical sample is contacted with the fixed genomic single stranded nucleic acid under hybridizing conditions. Hybridization of probes to the single stranded nucleic acid is diagnostic of the presence of the pathogen.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?